echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > JEADV: Prevalence and characteristics of refractory psoriasis and super-response to biological therapy

    JEADV: Prevalence and characteristics of refractory psoriasis and super-response to biological therapy

    • Last Update: 2022-05-14
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Biologics for the treatment of psoriasis act by inhibiting cytokines important in the pathogenesis of psoriasis, including tumor necrosis factor-alpha, interleukin 12/23, interleukin 17, and interleukin 23


    Identify and describe patients with treatment-refractory psoriasis and those who have had a significant response to biological therapy


    Patients enrolled in DERMBIO from January 2007 to November 2019 were included


    A total of 3280 patients were included, with a mean age of 45.


    All told, about 6% of patients treated with biologics had refractory psoriasis and 6% responded well


    Source: Loft N, Egeberg A, Rasmussen MK, Prevalence and characterization of treatment-refractory psoriasis and super-responders to biologic treatment: a nationwide study.




    leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.